Whalesbook
Analysts Spot Short-Term Trading Chances
Technical analysts are highlighting nine stocks for short-term trading opportunities on May 22, 2026. These picks aim to leverage favorable technical setups, even as major stock indices saw minor dips. Market breadth, however, suggests underlying strength.
Jay Mehta of JM Financial Services recommends Niva Bupa Health Insurance, noting a breakout from long-term consolidation. He suggests a 'Buy' with a target of ₹88.3 and a stop-loss at ₹79.
Mehta also favors Authum Investment & Infrastructure, citing a bullish head-and-shoulders pattern breakout supported by increasing trading volumes. His advice is a 'Buy' at ₹527.2, with targets of ₹578 and ₹635, and a stop-loss at ₹481.5. ACME Solar Holdings is another pick, recommended near its 50-day EMA support with targets of ₹310 and ₹333, and a stop-loss at ₹254.
Pharma and Auto Stocks Show Strength
Hitesh Tailor from Choice Broking is positive on Gland Pharma due to a horizontal breakout and sustained trading above this level. He recommends a 'Buy' at ₹2,331, targeting ₹2,580 with a stop-loss at ₹2,200. Gland Pharma has a market capitalization of over ₹37,910 crore and a P/E ratio of 28.15.
Thermax is also recommended for purchase at ₹4,575, with a target of ₹5,100 and a stop-loss of ₹4,325. Technical indicators point to a bullish trend for Thermax.
Samvardhana Motherson International is another selection, with a 'Buy' strategy at ₹137, targeting ₹151 and a stop-loss at ₹129. Its 14-day RSI is 62.013.
Om Mehra of Samco Securities highlights Aurobindo Pharma, noting its steady uptrend and support from a rising trendline. He suggests buying at ₹1,546.70, aiming for ₹1,630 with a stop-loss at ₹1,490. Aurobindo Pharma faces significant competition in the domestic and global markets.
Endurance Technologies is advised for purchase at ₹2,623, targeting ₹2,800 with a stop-loss at ₹2,530. Bajaj Auto is recommended at ₹10,667, targeting ₹11,250 with a stop-loss at ₹10,250. Bajaj Auto shows a strong buy outlook with its 14-day RSI at 62.912.
Market Performance and Technical Signals
Indian equity markets saw a mixed close on May 20, 2026, with the BSE Sensex gaining 118 points and the Nifty 50 rising 41 points. This occurred despite a weakening rupee and high crude oil prices affecting investor sentiment.
Samvardhana Motherson International shows strong buy signals from its technical indicators. Bajaj Auto also displays a 'Strong Buy' outlook. Thermax's RSI is 81.33, indicating it may be nearing overbought territory. Analysis suggests Gland Pharma might be overvalued by 38% based on a base case scenario.
Competitive Landscape and Valuation
In the pharmaceutical sector, Gland Pharma competes with Lupin Pharmaceuticals and Teva Pharmaceutical Industries, among others. Aurobindo Pharma's rivals include Sun Pharma and Cipla.
Bajaj Auto's main competitors in the auto sector are TVS, Honda, and Yamaha Motor. Thermax competes in the energy and environmental solutions space with companies like BHEL and ABB.
While many stocks are recommended for technical strength, fundamental analysis is also important. Thermax trades at a P/E ratio of 73.03, significantly above the sector average. Gland Pharma's P/E ratio of 29.94 is below its sector average, and it trades at 3.71 times its book value. Samvardhana Motherson International has a P/E ratio of 40.19, below its sector average.